Leading the way to safer medication
 Crosscheck  Recommender

Atorvastatin

Description

Atorvastatin is a selective, competitive inhibitor of HMG-CoA reductase. Atorvastatin lowers plasma cholesterol and lipoprotein serum concentrations by inhibiting HMG-CoA reductase and subsequently cholesterol biosynthesis in the liver and increases the number of hepatic LDL receptors on the cell surface for enhanced uptake and catabolism of LDL.

ATC Classification

Code
Title
Category
C10AA05
Atorvastatin
C Cardiovascular system → C10 Lipid modifying agents → C10A Lipid modifying agents, plain → C10AA HMG CoA reductase inhibitors

Trade names

Trade name
Countries

Cyprus

Singapore

Singapore

Austria

Singapore Spain

Austria

Singapore

Cyprus

Australia

Austria

Austria

Austria

Singapore

Singapore

Singapore

Austria

Spain

Cyprus

Singapore

Singapore

Cyprus

Australia Canada Cyprus Netherlands Singapore

Australia

Spain

Austria

France

Spain

Cyprus

Singapore

Australia

Singapore

Australia

Singapore

Spain

Trade names (in combination): ASTUCOR ATORVALAN COMP ATOZET CADIVAST CADUET EZEATO EZETAST LIPERCOSYL LIPTRUZET ORVATEZ RESELIP TRINOMIA TRIVERAM

Product Monographs

Monograph
Type
Country
LIPITOR Film-coated tablets
MPI, EU: SmPC
UK
LIPITOR Film-coated tablet
MPI, US: SPL/PLR
US